This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. (MRNA) sank 0.07% to $122.15 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 2.05% to 11,051.64 and the Dow Jones Industrial Average rising 1.88% to 29,683.74. Moderna Inc. closed $275.83 below its 52-week high ($397.98), which the company reached on September 29th.
The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. (ABBV) rose 2.03% to $144.60, Amgen Inc. (AMGN) rose 2.21% to $230.98, and AstraZeneca PLC ADR (AZN.LN) rose 2.72% to $54.69. Trading volume (4.2 M) remained 474,174 below its 50-day average volume of 4.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 28, 2022.
(END) Dow Jones Newswires
September 28, 2022 16:32 ET (20:32 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.